Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcgammaR1 (CD 64), FcgammaRIIA (CD 32a), and FcgammaRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers[1][2].
Molekulargewicht:
(146.73 kDa)
Reinheit:
99.82
CAS Nummer:
[509077-98-9]
Target-Kategorie:
CD3
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
